What is the difference between Jacobs (XYY) syndrome and Turner syndrome in a patient with 45,X/46,XY mosaicism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Jacobs Syndrome versus Turner Syndrome

Jacobs syndrome (47,XYY) and Turner syndrome (45,X) are fundamentally different chromosomal conditions: Jacobs syndrome affects phenotypic males with an extra Y chromosome, while Turner syndrome affects phenotypic females with a missing or structurally abnormal X chromosome.

Jacobs Syndrome (47,XYY)

Chromosomal Pattern and Phenotype

  • Jacobs syndrome is characterized by a 47,XYY karyotype where males have an extra Y chromosome, resulting in a phenotypically normal male appearance 1.
  • This condition represents a rare chromosomal abnormality that can be associated with male hypogonadism, though it is classified among "uncommon causes" of primary hypogonadism 1.

Clinical Manifestations

  • Males with 47,XYY typically present with normal male external genitalia and may go undiagnosed unless fertility issues or other concerns prompt karyotype analysis 1.
  • Array-based testing may miss XYY syndrome if the wrong gender control is used, representing an important technical limitation of chromosomal microarray analysis 1.
  • The condition is associated with potential fertility impairment, and karyotype testing should be recommended for males with primary infertility and azoospermia or sperm concentration <5 million sperm/mL when accompanied by elevated FSH or testicular atrophy 1.

Turner Syndrome (45,X)

Chromosomal Pattern and Phenotype

  • Turner syndrome is characterized by complete or partial absence of one X chromosome (45,X karyotype) in phenotypic females, resulting in short stature, gonadal dysgenesis, and various somatic features 2.
  • Mosaic forms exist, including 45,X/46,XX mosaicism, which may present with variable phenotypic severity 1.

Clinical Manifestations

  • Classic features include short stature, ovarian dysgenesis leading to primary amenorrhea, and Turner stigmata such as webbed neck, low posterior hairline, and cardiac anomalies 2, 3.
  • Females with Turner syndrome typically require puberty induction due to gonadal failure and are at risk for associated conditions including cardiac defects, renal anomalies, and hearing loss 4.
  • Noninvasive prenatal screening (NIPS) for monosomy X has a positive predictive value of only 29.5%, lower than other sex chromosome aneuploidies, partly due to higher rates of placental mosaicism and maternal mosaicism for 45,X 1.

The Special Case: 45,X/46,XY Mosaicism

Clinical Spectrum

  • 45,X/46,XY mosaicism represents a distinct entity that bridges the phenotypic spectrum between Turner syndrome and normal male development, accounting for 10-12% of Turner syndrome cases 2.
  • This karyotype presents with highly variable phenotypes: approximately 60% present with ambiguous genitalia, 11-12% present as phenotypically normal males with bilateral descended testes, and some present as phenotypic females with Turner features 3, 5, 6.

Sex Assignment and Clinical Features

  • Of patients with 45,X/46,XY mosaicism and genital anomalies, approximately 61% are raised male and 39% female, with management individualized based on anatomical assessment 5.
  • Phenotypic males with 45,X/46,XY may present with short stature, Turner-like stigmata, and normal male external genitalia, often going unrecognized until evaluation for growth retardation 3.
  • Females with 45,X/46,XY are significantly shorter than males with the same karyotype, and height Z-score decreases with age for both genders 4.

Gonadal Pathology and Tumor Risk

  • The presence of Y chromosome material in 45,X/46,XY mosaicism confers significant gonadoblastoma risk, particularly in individuals with gonadal dysgenesis 1.
  • Gonadoblastoma risk in individuals with 46,XY karyotype and gonadal dysgenesis exceeds 40%, with occurrences reported from infancy through young adulthood 1.
  • Prophylactic gonadectomy is generally recommended for dysgenetic gonads in 45,X/46,XY individuals, particularly those raised female or with intra-abdominal gonads 2, 5, 4.
  • Gonadal histology in 45,X/46,XY is highly variable: intra-abdominal gonads are typically dysgenetic testes or streak gonads, while palpable scrotal gonads may include histologically normal testes, dysgenetic testes, or streak gonads 5.

Fertility Considerations

  • Males with 45,X/46,XY mosaicism may develop azoospermia, as documented in case reports of phenotypically normal males with this karyotype 3.
  • All females with 45,X/46,XY typically require puberty induction, contrasting with the majority of males who undergo spontaneous puberty 4.

Surveillance Requirements

  • Boys with 45,X/46,XY mosaicism require thorough clinical evaluation similar to girls with Turner syndrome, including cardiac and renal screening, as approximately 58% exhibit at least one Turner syndrome stigmata 3, 4.
  • Growth hormone treatment in 45,X/46,XY mosaicism has shown variable results, with some studies reporting poor response 3, 4.
  • Routine follow-up is essential for monitoring late-onset abnormalities including infertility and gonadal tumors in phenotypically normal males with this karyotype 3.

Key Diagnostic Pitfalls

  • Conventional karyotyping remains superior to chromosomal microarray for detecting sex chromosome aneuploidies when rapid diagnosis is needed or when specific aneuploidies are suspected 1.
  • Boys with unexplained short stature who are short for their families should undergo karyotype analysis, as 45,X/46,XY mosaicism may present solely with growth retardation in phenotypically normal males 3.
  • The clinical spectrum of 45,X/46,XY does not conform to a set pattern, requiring individualized anatomical and histological assessment rather than assumptions based on karyotype alone 5, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.